Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer

Journal of Clinical Microbiology

Volumn 50, Issue 1, 2012, Pages 194-195

  Bark, Charles M ^a   Traboulsi, Rana S ^a   Honda, Kord ^b   Starnes, Autumn M ^b   Jacobs, Michael R ^b   Rodriguez, Benigno ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBOPLATIN; CEFOXITIN; CETUXIMAB; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; DOXYCYCLINE; GEMCITABINE; IMIPENEM; METICILLIN; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACID FAST BACTERIUM; ADULT; ADVANCED CANCER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FATIGUE; FEMALE; FEVER; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HOSPICE CARE; HUMAN; LARYNGECTOMY; LUNG INFILTRATE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIPLE CYCLE TREATMENT; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; NECK DISSECTION; PLEURA EFFUSION; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT REFUSAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOPSY; FEMALE; HEAD AND NECK NEOPLASMS; HISTOCYTOCHEMISTRY; HUMANS; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SKIN; SKIN DISEASES, BACTERIAL;

MYCOBACTERIUM CHELONAE;

EID: 84555196118     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05399-11     Document Type: Article

References (12)

1. Bermudez LE, Petrofsky M, Shelton K. 1996. Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect. Immun. 64:2917-2922. (Pubitemid 26256125)
2. Bonner JA, et al. 2006. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354:567-578. (Pubitemid 43209104)
3. Brown-Elliott BA, Wallace RJ, Jr. 2002. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin. Microbiol. Rev. 15:716-746. (Pubitemid 41199631)
4. Cunningham D, et al. 2004. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 351:337-345. (Pubitemid 38944402)
5. Diaz F, et al. 2008. Mycobacterium chelonae infection associated with adalimumab therapy. Scand. J. Rheumatol. 37:159-160. (Pubitemid 351536080)
6. Eilers RE, Jr, et al. 2010. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J. Natl. Cancer Inst. 102:47-53.
7. Jonker DJ, et al. 2007. Cetuximab for the treatment of colorectal cancer. N. Engl. J. Med. 357:2040-2048. (Pubitemid 350106711)
8. Li T, Perez-Soler R. 2009. Skin toxicities associated with epidermal growth factor receptor inhibitors. Target Oncol. 4:107-119.
9. Matsuo T, et al. 2011. Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models. BMC Res. Notes 4:140.
10. Steingrube VA, et al. 1995. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J. Clin. Microbiol. 33:149-153. (Pubitemid 24382417)
11. Vermorken JB, et al. 2008. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 359:1116-1127.
12. Wallace RJ, Jr, Brown BA, Onyi GO. 1992. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J. Infect. Dis. 166:405-412.